Current:Home > ContactEli Lilly's new ad says weight-loss drugs shouldn't be used out of "vanity" -TradeBridge
Eli Lilly's new ad says weight-loss drugs shouldn't be used out of "vanity"
View
Date:2025-04-14 20:37:56
Eli Lilly has a message for people who are taking prescription medications developed for patients with Type 2 diabetes and obesity: Don't take the drugs just because you want to look good.
The message, delivered in a new Hollywood-themed ad called "Big Night," will air this weekend and is timed to coincide with Sunday's broadcast of the Oscars. The spot opens with a shot of a sequined gown, suggesting that the woman voicing the campaign is preparing for a formal event.
"Some people have been using medicine never meant for them. For the smaller dress or tux, for a big night, for vanity," the character in the ad says. The camera then pans to a theater resembling the one in which the Academy Awards are handed out. The point is clear: Drugs like Lilly's Mounjaro or Novo Nordisk's Ozempic and Wegovy aren't intended for general weight loss.
"People whose health is affected by obesity are the reason we work on these medications. It matters who gets them," the ad says.
Mounjaro is used to treat patients with Type 2 diabetes. But the drug and similar medications have soared in popularity among people who aren't diabetic but who want to shed a few pounds to improve their appearance. Lilly also makes Zepbound, which is indicated for adults with obesity.
This year's Oscars host, Jimmy Kimmel, opened the 2023 awards ceremony by poking fun at Ozempic.
"Everybody looks so great. When I look around this room I can't help but wonder, 'Is Ozempic right for me?'" he quipped.
"Part of the cultural dialogue"
In a statement ahead of its new ad, Lilly underlined that people shouldn't take drugs like Mounjaro just because they want to be slimmer.
The ad "addresses a topic that has been part of the cultural dialogue at recent high-profile awards ceremonies: the use of anti-obesity medications outside their FDA-approved indications," the company said. "Patient safety is Lilly's top priority, and our medicines are indicated for the treatment of serious diseases."
The drugmaker also makes clear that the medications are only approved for certain uses.
"They were not studied for, are not approved for, and should not be used for cosmetic weight loss, and at Lilly we believe it is important that, in consultation with their health care providers, the right people can get access to these medicines," Lilly said.
In a separate open letter regarding how such drugs are use, Lilly said "stands against the use of its medicines for cosmetic weight loss."
Megan CerulloMegan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News Streaming to discuss her reporting.
veryGood! (6873)
Related
- This was the average Social Security benefit in 2004, and here's what it is now
- What restaurants are open Thanksgiving? Details on Starbucks, McDonald's, fast food, more
- Prince Harry to appeal to UK government for evidence in lawsuit against Daily Mail publisher
- Father of Taylor Swift Fan Who Died in Brazil Speaks Out on Tragedy
- Israel lets Palestinians go back to northern Gaza for first time in over a year as cease
- Analysis: Iran-backed Yemen rebels’ helicopter-borne attack on ship raises risks in crucial Red Sea
- Bahrain government websites briefly inaccessible after purported hack claim over Israel-Hamas war
- Officials identify man fatally shot on a freeway by California Highway Patrol officer
- New data highlights 'achievement gap' for students in the US
- Has Elon Musk gone too far? Outrage grows over antisemitic 'actually truth' post
Ranking
- All That You Wanted to Know About She’s All That
- Trump has long praised autocrats and populists. He’s now embracing Argentina’s new president
- Powerball winning numbers for Nov. 20 drawing: Jackpot rises over $300 million
- Founder of far-right Catholic site resigns over breach of its morality clause, group says
- North Carolina trustees approve Bill Belichick’s deal ahead of introductory news conference
- Anti-abortion groups shrug off election losses, look to courts, statehouses for path forward
- A fan died of heat at a Taylor Swift concert. It's a rising risk with climate change
- Oscar Pistorius will have another chance at parole on Friday after nearly a decade in prison
Recommendation
Paula Abdul settles lawsuit with former 'So You Think You Can Dance' co
NATO head says violence in Kosovo unacceptable while calling for constructive dialogue with Serbia
First 'Love is Blind' baby incoming: Bliss Poureetezadi, Zack Goytowski announce pregnancy
Quiet, secret multimillionaire leaves tiny New Hampshire hometown his fortune
FACT FOCUS: Inspector general’s Jan. 6 report misrepresented as proof of FBI setup
Man found guilty of decapitating ex-girlfriend with samurai sword in middle of California street
Federal judge says Pennsylvania mail-in ballots should still count if dated incorrectly
NFL fans are rooting for Taylor and Travis, but mostly they're rooting for football